Taxotere is a chemotherapy drug indicated for treatment of breast cancer as well as other cancers such as stomach, prostate and non-small cell lung cancer. However, prior to the upgrade, the tag on Taxotere stated that “hair generally grows taxotere alopecia back” once chemotherapy treatment has been completed. “Everybody expects me to return to normal now that my cancer treatments are over. ” A 2008 study published in the New England Journal of Medicine (NEJM) found no significant difference in survival rates between cancer patients treated with Taxotere and people taking Taxol (generic: pacitaxel), another chemotherapy drug which hasn’t been linked to permanent alopecia. 3% of breast cancer patients grew back less than 50% of the hair after they were given Taxotere, especially when given in combination with Adriamycin (doxorubicin) and Cytoxan (cyclophosphamide). Sanofi sponsored a study called GEICAM 9805. Currently, there is a litigation consolidated in the Eastern District of Louisiana. How Taxotere Lawsuits Are Filed?
It is thought that if patients were advised of the risk, many might have chosen an alternate drug which did not carry the danger of baldness. Alopecia Universalis — alopecia’s form, presenting as the loss of hair. ” However, it is feared that physicians who were not conscious of the lack of evidence supporting the claims may have continued to favor the drug in treating breast cancer patients with no understanding of the further risk of permanent alopecia. June 6, 2017 — The federal multidistrict litigation (MDL No. 2740) for lawsuits alleging permanent baldness or “alopecia” from Taxotere has grown from only a handful of cases under a year ago to over 1,100 complaints, according to a joint report issued last month. Produced by French pharmaceutical giant, Sanofi-Aventis, Taxotere (docetaxel) was accepted by the U.S. Food and Drug Administration in 1996 as a chemotherapy drug to mostly combat breast cancer. Sanofi, et al. (2016). 2 billion in 2004. Plaintiff Ami Dodson claims its affiliates and Sanofi collaborated to increase sales of Taxotere — a plan that caused thousands of cancer patients to suffer hair loss, baldness and alopecia. The risk of permanent Taxotere hair loss was never mentioned until December 2015 when the FDA issued a label change noting that cases of permanent alopecia (hair loss) have been reported.
The plaintiffs also assert that Sanofi hid data and research that linked these adverse side effects and Taxotere. U.S. District Court for the Northern District of California. Close Byetta Celexa Cipro Lawsuit SettlementsFAQs About Cipro Close FAQs About Cipro Close Concerta LawsuitFAQs About Concerta Side Effects CloseEffexorFAQs About Effexor CloseLevaquin Lawsuit SettlementsFAQs About Levaquin CloseGranuFloFAQs About GranuFlo CloseInvokana Lawsuit Claims & SettlementsFAQs About Invokana CloseFosamaxJanumetJanuviaLexaproLipitorOmontys Concerta LawsuitFAQs About Concerta Side Effects Close FAQs About Concerta Side Effects Close EffexorFAQs About Effexor Close FAQs About Effexor Close Levaquin Lawsuit SettlementsFAQs About Levaquin Close FAQs About Levaquin Close GranuFloFAQs Around GranuFlo Close FAQs About GranuFlo Close Invokana Lawsuit Claims & SettlementsFAQs About Invokana Close FAQs About Invokana Close Fosamax Janumet Januvia Lexapro Lipitor Omontys Onglyza Lawsuit Claims SettlementsPlavixPradaxaFAQs About Pradaxa ClosePropeciaFAQs About Propecia CloseProton Pump Inhibitor PPIs lawsuitFAQs About Proton Pump Inhibitors PPIs CloseRisperdalFAQs About Risperdal CloseTaxotere hair loss lawsuitTaxotere Hair Loss AttorneysFacts & FAQs about Taxotere CloseTestosterone therapy Lawsuit Claims & Settlements Blood clots, Heart attack, strokeXarelto LawsuitList of Xarelto Questions Frequently Asked QuestionsFAQs About Xarelto CloseZofranFAQs Around ZofranZofran Birth Defects Lawsuit CloseViagra Skin Cancer LawsuitViagra Claims Evaluation Close Onglyza Lawsuit Claims Settlements Plavix PradaxaFAQs About Pradaxa Close FAQs About Pradaxa Close PropeciaFAQs About Propecia Close FAQs About Propecia Close Proton Pump Inhibitor PPIs lawsuitFAQs Around Proton Pump Inhibitors PPIs Close FAQs About Proton Pump Inhibitors PPIs Close RisperdalFAQs Around Risperdal Close FAQs About Risperdal Close Taxotere baldness lawsuitTaxotere Hair Loss AttorneysFacts & FAQs about Taxotere Close Taxotere Hair Loss Attorneys Facts & FAQs about Taxotere Close Testosterone therapy Lawsuit Claims & Settlements Blood clots, Heart attack, stroke Xarelto LawsuitList of Xarelto Questions Frequently Asked QuestionsFAQs About Xarelto Close List of Xarelto Questions Frequently Asked Questions FAQs About Xarelto Close ZofranFAQs About ZofranZofran Birth Defects Lawsuit Close FAQs About Zofran Zofran Birth Defects Lawsuit Close Viagra Skin Cancer LawsuitViagra Claims Evaluation Close Viagra Claims Assessment Close ProscarProzacSSRI Birth DefectsTestim Lawsuit Claims & Settlements for Blood clots, Heart attack, StrokeTopamaxTylenolFAQs About ViagraVictozaZ-PakZofran Claims CanadaZoloft Proscar Prozac SSRI Birth Defects Testim Lawsuit Claims & Settlements for Blood clots, Heart attack, Stroke Topamax Tylenol FAQs About Viagra Victoza Z-Pak Zofran Claims Canada Zoloft Close. Hattie Carson was among the first plaintiffs to file a claim against Sanofi for failing to warn physicians or patients about the true dangers of permanent or long-term alopecia. The fact that Taxotere failed to disclose that this and was aware of the potential for hair loss that is permanent is of itself grounds for conducting a lawsuit. In men the emotion effect might not be a great as in girls, but the simple fact remains that the producers of Taxotere were negligent in disclosing the fact that around 10% of individuals will experience permanent hair loss. I not sure.
2 percent of women who used the chemo drug suffered permanent alopecia. Scalp alopecia linked to breast cancer: a prospective study of 20 patients. Sometimes, hair may become duller or dryer and will simply become thin. After she had a partial mastectomy, Dodson spoke with her doctor about chemotherapy.
Taxotere is used in combination with other drugs such as capecitabine, cisplatin, fluorouracil, doxorubicin and cyclophosphamide to fight off cancer and provide patients with greater survival prices. The doctor assured her that her hair would grow back immediately following completing treatment with the drug; nonetheless, 5 years later and she is still bald. Evidence linking Taxotere side effects to permanent hair loss in breast cancer patients has been mounting for years: “The one side effect possibly most feared by the individual is alopecia,” wrote Dr. Sedlacek. Taxotere falls under a specific class of chemotherapy treatments known as taxane drugs — made from plant alkaloids. Scientific and FDA Studies Regarding Taxotere. Join this Taxotere lawsuit evaluation now by filling out the form on this page! The following is a list of frequently asked questions (FAQ) about Taxotere, a chemotherapy drug that’s been associated with reports of permanent hair loss (alopecia). Taxotere has also been approved to treat non-small cell lung cancer (NSCLC), prostate cancer, head and neck cancers, and stomach cancer (gastric adenocarcinoma). Prostate cancer: Taxotere has been approved by the FDA on May 19, 2004 for use in combination with prednisone (a steroid) for the treatment of advanced metastatic prostate cancer. Once their merchandise information was updated, lawsuits began to be filed against them for failing to warn consumers of this devastating risk.
But I can’t. April 18, 2017 — The federal Taxotere litigation (MDL No. 2740) continues to grow at a fast rate, with at least 949 claims filed on behalf of cancer patients who allegedly suffered permanent hair loss or “alopecia” after undergoing chemotherapy with the drug. Retrieved from Potts, J. (2015, September 3). In a nationwide drug lawsuit like the Taxotere cases, the location of the lawyer does not matter. ” Despite this research that is expanding, nobody was telling patients that their breast cancer treatment could leave them permanently hairless. Can alopecia is caused by Taxotere?